BioCentury
ARTICLE | Company News

NeuroVive, Arbutus Biopharma deal

October 31, 2016 7:00 AM UTC

NeuroVive and Arbutus terminated a 2014 deal that granted OnCore Biopharma Inc. exclusive, worldwide rights to NVP018 to treat HBV infection. OnCore merged with Tekmira Pharmaceuticals Corp. in 2015 t...